Treatment Resistant Depression Clinical Trials in New York, New York

6 studies are recruiting for treatment resistant depression in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

    The goal of this clinical trial is to evaluate the effectiveness and safety of bilateral stimulation of the subcallosal cingulate white matter (SCCwm) using Deep Brain Stimulation (DBS) as an adjunctive treatment of non-psychotic unipolar Major Depressive Disorder (MDD) in adults.

    Stage
    Not phased
    Ages
    22 to 70
    Site
    Mount Sinai Hospital, New York, New York
    Locations
    25 in total
    Run by
    Abbott Medical Devices
  2. DBS for TRD With the Medtronic Percept PC

    Of the estimated 30 million Americans who suffer from Major Depressive Disorder, approximately 10% are considered treatment resistant. Deep brain stimulation (DBS) to a region of the brain called the subcallosal cingulate (SCC) is an emerging strategy for treatment resistant depression (TRD), which…

    Stage
    Not phased
    Ages
    25 to 70
    Site
    Icahn School of Medicine at Mount Sinai, Mount Sinai West, New York, New York
    Run by
    Helen Mayberg, MD
  3. A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

    Objectives of this study are to determine whether active VNS Therapy treatment is superior to a no stimulation control in producing a reduction in baseline depressive symptom severity, based on multiple depression scale assessment tools at 12 months from randomization.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Icahn School of Medicine at Mount Sinai, New York, New York
    Locations
    101 in total
    Run by
    LivaNova
  4. A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

    This Phase 2 study (protocol number VLS-01-203) will determine the efficacy, safety, and tolerability of short-term treatment with a VLS-01 transmucosal buccal film (VLS-01-BU) in patients with treatment resistant Major Depressive disorder (TRD) and will characterize the onset and durability of ant…

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    The Medical Research Network, LLC, New York, New York
    Locations
    48 in total
    Run by
    atai Therapeutics, Inc.
  5. Maintenance rTMS for Depression (Maitr-De)

    Repetitive transcranial magnetic stimulation (rTMS) has emerged as a promising intervention for treatment-resistant depression (TRD), yet substantial uncertainties persist regarding its efficacy as a maintenance treatment. This prospective study seeks to investigate the efficacy of maintenance rTMS…

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Weill Cornell Medicine, New York, New York
    Locations
    3 in total
    Run by
    University of California, San Diego
  6. Biomarker-guided rTMS for Treatment Resistant Depression

    Repetitive transcranial magnetic stimulation (rTMS) is a treatment for depression. The investigators are continuing to learn how to optimize outcomes from rTMS treatment. The purpose of this research project is to use brain network connectivity patterns as measured by resting state functional magne…

    Stage
    Phase 3
    Ages
    22 to 65
    Site
    Weill Cornell Medicine, New York, New York
    Locations
    2 in total
    Run by
    Weill Medical College of Cornell University

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.